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Beyond the Hospital 
Doors – The Future of 
Transitions of Care
Lorena Berrios Caldero
PGY-1 Pharmacy Resident
West Kendall Baptist Hospital
Objectives
1. Define transitions of care (TOC) and the 
pharmacist’s role during this process
2. Identify challenges present in the process 
of transitioning patients from secondary 
to primary care 
3. Describe strategies for the optimization 
of TOC services after hospital discharge
2
Transitions of Care
The movement of 
patients between health 
care practitioners, 
settings and home as 
their condition and care 
needs change. 
https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Importance
 The need for effective patient discharge 
from the hospital is increasing because of:
 Rising number of transitions of elderly and 
chronically ill patient between various 
healthcare institutions
 Shorter hospital stays
 Growing effort to deliver care in the 
community 
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Regulatory and Financial 
Impact on Hospitals
The Patient Protection and Affordable Care Act
 Penalties enacted on hospitals with high readmission rates:
 2012: Heart failure, myocardial infarction, and pneumonia
 2015: Total hip and knee replacements and chronic obstructive 
pulmonary disease (COPD) exacerbations
 2017: Coronary artery bypass graft (CABG)
 For 2019, penalties based on a hospital’s performance 
relative to other hospitals treating a similar proportion of 
Medicare patients
https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html
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Regulatory and Financial 
Impact on Hospitals
Centers for Medicare and Medicaid Services 
(CMS)
 2013: 1% penalization for hospital readmission 
 2015: Increased penalties to 3%
The Joint Commission  
 National Patient Safety Goal 03.06.01
 Maintain and communicate accurate patient 
medication information
http://www.jointcommission.org/core_measure_sets.aspx
https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html
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Challenges in TOC
Communication 
Patient 
Education
Accountability 
Medication-
related 
Challenges
https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Communication 
Breakdowns
 Expectations differ between senders and 
receivers of patients in transition
 Culture does not promote successful 
hand-off
 Lack of standardized procedures
 Inadequate amount of time provided for 
successful hand-off
https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Patient Education 
Breakdowns
 Lack of understanding of the medical 
condition or the plan of care
 Exclusion of patients/caregivers from 
the planning of transition process
Conflicting recommendations and 
unclear instructions
https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Accountability 
Breakdowns
 No provider or clinical entity takes 
responsibility of coordinating care across 
settings
 Multiple providers involved in patient’s care
 Every year, the average elderly patient sees 7 
physicians 
https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Medication-Related 
Challenges
 Inaccurate documentation during hospital stay
 Prescribing errors
 Inaccurate medication profile at discharge
 Polypharmacy
 Inadequate patient education on discharge 
medications
 Failure to provide patient follow-up
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Deficits in Communication and Information 
Transfer Between Hospital-Based and 
Primary Care Physicians: Implications for 
Patient Safety and Continuity of Care
 Evaluate the prevalence of deficits in 
communication and information transfer
Information related to 
medications missing 
from discharge 
summary 40% of the 
time
Low availability of 
discharge summary 
for outside provider 
to review increased 
prescribing errors 
Patient or family 
counseling (92%) 
and follow-up plan 
(43%) not available 
Medication-related problems Communication breakdowns Patient education breakdowns
Kripalani S, LeFevre F, Phillips CO, et. al. Deficits in communication and information transfer between hospital-based and 
7primary care physicians: implications for patient safety and continuity of care. J Amer Med Assoc. 2007;297(8):831-841.
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Implications to Patient 
Outcomes
 One in 5 patients has an adverse event 
after hospital discharge
 Approximately 62% of these adverse 
events are preventable 
 More than 60% of hospital readmissions 
occur as a result of medication-related 
problems that are unresolved at hospital 
discharge 
https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
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Pharmacist’s Role
 During discharge:
 Medication reconciliation
 Patient education and communication
 Meds to beds
 Immediately post-discharge:
 Follow-up phone calls 
 Post-discharge clinics
 In clinics:
 MTM visits
 Provider collaboration 
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Patient Case
 63 year old female with a past medical history of 
Chronic Obstructive Pulmonary Disease admitted to 
the hospital due to an exacerbation
 Smokes 1 pack per day and states she does not use 
the inhalers prescribed by her doctors
 During her hospital stay she was educated on the 
importance of smoking cessation and medication 
adherence to prevent further 
exacerbations 
 After 5 days in the hospital, she is 
ready to go home
19
Medication Reconciliation
 The comprehensive evaluation of a patient’s 
medication regimen any time there is a change in 
therapy in an effort to avoid medication errors 
such as:
 Omissions
 Duplications
 Dosing errors
 Drug interactions
 Observe a patient’s compliance and adherence 
patterns
https://www.pharmacist.com/sites/default/files/files/2012_improving_care_transitions.pdf
20
Medication Reconciliation
Medication Reconciliation at Hospital Discharge: 
Evaluating Discrepancies 
Objective
•To identify, characterize, and assess the clinical impact of unintentional 
medication discrepancies at hospital discharge.
Methods
•Assessment of medication discrepancies through comparison of a best possible 
medication discharge list with the actual discharge prescriptions. 
Results
•From the 150 patients included in the study, 106 (70.7%) had at least one 
unintentional discrepancy.
Conclusion
•Structured medication reconciliation may help to prevent discharge medication 
discrepancies.
Wong JD, et. al. Ann Pharmacother. 2008; 42:1373-1379. 21
Discharge Counseling
22
Discharge Counseling
Role of Pharmacist Counseling in Preventing Adverse 
Drug Events After Hospitalization 
Objective
•To identify drug related problems during and after hospitalization and to 
determine the effect of patient counseling and follow-up by pharmacist on 
preventable ADEs. 
Methods
•Patients were randomized into the control group (n=84) who received usual 
care or the intervention group (n=92) who received discharge counseling by a 
pharmacist. 
Results
•At 30 days after discharge, preventable ADEs were detected in 11% of 
patients in the control group and 1% of patients in the intervention group 
(p=0.01)
Conclusion
•Discharge counseling by a pharmacist was associated with a lower rate of 
preventable ADEs 30 days after hospital discharge.
Schnipper JL, et al. Arch Intern Med. 2006;166:565-571. 23
Meds to Beds
 Hand-delivery of prescriptions to hospital 
patients at bedside before discharge
 Identification and resolution of potential 
barriers to compliance prior to hospital 
discharge
 Medications not covered by insurance
 High co-pays
 Coordination of prior authorizations
 Transportation
https://www.pharmacist.com/article/meds-beds-programs-prevent-rehospitalization
24
Meds to Beds
The average time to fill these 
prescriptions is 20 minutes
Has been shown to decrease 
readmission rates
Potential for the pharmacy 
providing the service to 
retain the customer
https://www.cardinalhealth.com/content/dam/corp/web/documents/brochure/Cardinal-Health-CaseStudy-Hackensack-Bedside.pdf
https://www.mckesson.com/blog/pharmacists-partnering-with-hospitals-to-improve-outcomes/
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Patient Case
 Patient was discharged on Spiriva and Symbicort
 She had been using nicotine patches during her hospital stay 
and stated she was ready to quit smoking and the patches had 
helped her
 During medication reconciliation, the discharge pharmacist 
noticed there were no nicotine patches in the patient’s 
medication list 
 After talking to the doctor and getting a
prescription for nicotine patches, the 
discharge pharmacist went to the 
patient’s room and provided counseling 
regarding inhaler technique and proper 
patch use.
26
Beyond the hospital doors!
Bridging the gap in care…
Follow-up Phone Calls
 The pharmacist calls the patient usually 
72 hours after discharge
 Concerns related to medications
 Problems accessing medications
 Patient education reinforcement
 Follow-up reminder 
28
Follow-up Phone Calls
A Reengineered Hospital Discharge Program to 
Decrease Rehospitalization: A Randomized Trial
Objective
•To test the effects of an intervention designed to minimize hospital utilization 
after discharge.
Methods
•Patients were randomly assigned to the intervention group where they 
received a follow-up phone call by a clinical pharmacist 2-4 days after 
discharge or to the control group where they received usual care.   
Results
•Participants in the intervention group had a lower rate of hospital utilization 
than those receiving usual care (0.314 vs 0.451 visits/person/month; 
p=0.009).   
Conclusion
•Follow-up phone calls by a clinical pharmacist minimize hospital utilization 
after discharge. 
Jack BW, et. al. Ann Intern Med. 2009;150(3):178-187. 29
Follow-up Phone Calls
Post-discharge Pharmacist Medication Reconciliation: 
Impact on Readmission Rates and Financial Savings
Objective
•To assess the impact of ambulatory clinical pharmacist medication therapy 
assessment and reconciliation for patients post-discharge in terms of hospital 
readmission rates, financial savings, and medication discrepancies.  
Methods
•Patients in the intervention group received a phone call from a pharmacist 3-7 
days post-discharge and patients in the comparison group did not receive 
clinical pharmacist intervention.  
Results
• Patients in the intervention group had decreased readmission rates at 7 (0.8% vs. 0.4%; 
p=0.01), 14 (5% vs 9%; p=0.04), and 30 (12% vs 14%; p=0.29) days post-discharge
• Financial savings for patients in the intervention group was estimated to be more than 
$1,500,000 annually   
Conclusion
•Medication assessment and reconciliation by pharmacist 3-7 days post-
discharge can decrease readmissions and provide cost-savings
Kilcup M, et. al. J Am Pharm Assoc. 2013;53:78-84. 30
Post-Discharge Clinics 
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Post-Discharge Clinics
Pharmacist-Coordinated Multidisciplinary Hospital 
Follow-up Visits Improve Patient Outcomes 
Objective
•To compare hospital readmission rates and interventions in a multidisciplinary 
team visit coordinated by a clinical pharmacist practitioner with those 
conducted by a physician-only team within an internal medicine hospital 
follow-up program. 
Methods
•Retrospective review of follow-up visits within 7 days of discharge performed 
by a multidisciplinary team (physician and pharmacist) vs a physician-only 
team. 
Results
•Patients seen by the multidisciplinary team had a 30-day readmission rate of 
14.3% compared with 34.3% by the physician-only team (p=0.010).
•Interventions were higher in the multidisciplinary team  
Conclusion
•Hospital follow-up visits coordinated by the multidisciplinary team decreased 
30-day hospital readmission rates compared with follow-up visits by a 
physician-only team. 
Cavanaugh JJ, et. al. J Manag Care Spec Pharm. 2015;21(3):256-260. 32
Post-Discharge Clinics
Evaluation of Pharmacist Involvement in Outpatient 
Transitions of Care 
Objective
•To assess the impact of pharmacist involvement on the identification and 
resolution of medication discrepancies during post-discharge follow-up 
appointments.
Methods
•Retrospective: patients discharged from the hospital who already had a follow-
up visit without a pharmacist
•Prospective: patients discharged from the hospital who had a follow-up visit 
scheduled with a pharmacist  
Results
•An increase of 6.2 discrepancies addressed per patient (3.4 in the 
retrospective analysis vs 9.6 in the prospective population; p=0.0003)
Conclusion
•Pharmacist involvement in outpatient-based transitions of care process 
significantly increased medication discrepancies addressed by the patient’s 
PCP following discharge from the hospital to home. 
Whalley AS, et. al. J Gen Intern Med. 2018;33(8):1227-1228. 33
Patient Case
 72 hours after discharge, the pharmacist called the 
patient to reinforce what they had talked about during 
discharge counseling and to make sure the patient 
was not experiencing any problems 
 The patient stated that she was not able to get one of 
the inhalers because her insurance did not cover it. 
After looking into it, the pharmacist noticed a prior 
authorization was needed.
 Prior authorization process was 
initiated and follow-up appointment 
was confirmed with the patient
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MTM Visits
Medication Therapy Management (MTM) 
 A range of services provided to individual 
patients to optimize therapeutic outcomes and 
detect and prevent costly medication problems 
 Review of all medications prescribed by all 
prescribers providing care to the patient 
 Medication-related education 
 Collaboration with healthcare providers to develop 
and achieve optimal goals 
https://www.accp.com/docs/govt/advocacy/Leadership%20for%20Medication%20Management%20-%20MTM%20101.pdf
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Pharmacist-led MTM Clinics
The Effect of Clinical Pharmacist-Led Comprehensive Medication 
Management on Chronic Disease State Goal Attainment in a Patient-
Centered Medical Home
Objective
•To assess the effect of pharmacist-led comprehensive medication management 
(CMM) on therapeutic goal attainment rates for glycemic, blood pressure, and 
dyslipidemia outcomes.
Methods
•Patients managed within the primary care network who had diabetes were 
included in the intervention group that was compared to a control group made 
up of patients who didn’t have access to a primary care network pharmacist.
Results
•Patients in the intervention group had significantly higher rates of goal 
attainment for the 3 endpoints (p<0.001)
Conclusion
•Addition of CMM services provided by a clinical pharmacist had a positive 
effect on therapeutic goal attainment rates for patient with diabetes. 
Prudencio J, et al. J Manag Care Spec Pharm. 2018;24(5):423-429. 36
Community Pharmacist 
and MTM
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Community Pharmacist 
 Often the first member of the health care team 
that interacts with the patient post-discharge 
 Evidence supports that community pharmacists 
can:
 Identify and resolve medication-related problems
 Reduce 30-day readmission rates 
 Reduce ED utilization 
Melody KT, McCartney E, Sen S, et. al. Optimizing care transition: the role of the community pharmacist. Integ
Pharm Research and Prac. 2016;5:43-51.
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Community Pharmacist 
TransitionRx: Impact of community pharmacy post-discharge 
medication therapy management on hospital readmission rate
Objective
•To determine if a community pharmacy-based TOC program that includes the 
full scope of MTM services decreases hospital readmissions, resolves 
medication-related problems, and increased patient satisfaction.
Methods
•Patients discharged from the hospital with a diagnosis of CHF, COPD, or 
pneumonia were recruited and referred to the community pharmacy for MTM 
services with the pharmacist within 1 week of discharge
Results
•20% of patients in the usual care group were admitted to the hospital within 
30 days compared with 6.9% of patients in the intervention group (p=0.019)
Conclusion
•Community pharmacies successfully collaborate with hospitals to develop a 
referral process for TOC interventions
Luder HR, et. al. J Am Pharm Assoc. 2015;55(5):246-254. 39
Community Pharmacist can 
have impact beyond MTM
40
Discrepancies
Barriers to Implementing 
TOC in the Community
 The biggest concern for community 
pharmacists is the time required to 
provide TOC services 
 Workflow changes 
 Delegation of task to appropriate personnel 
Melody KT, McCartney E, Sen S, et. al. Optimizing care transition: the role of the community 
pharmacist. Integ Pharm Research and Prac. 2016;5:43-51.
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Telepharmacy
 Has been shown to overcome barriers to 
health services caused by access to care
 Technology already available
42Lee AC, et al. Inform Prim Care. 2012;20(4):263-260.
Provider Collaboration 
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Collaborative Practice 
Agreements
 Create a formal practice relationship between a 
pharmacist and other health care providers
 Specify what patient care services can be 
provided 
 Allow physician and pharmacists to share 
responsibility for patient outcomes
 State laws and regulations authorizing CPAs are 
highly variable
Joseph T, et. al. J Manag Care Spec Pharm. 2017;23(5):541-548. 44
Provider Collaboration
A Review of Advances in Collaborative Pharmacy Practice to 
Improve Adherence to Standards of Care in Diabetes 
Management
 Settings with collaborative practice agreement between 
pharmacists and physicians achieve better HbA1C control
 HbA1C reduction ≥1%: 79% (n=28)
 HbA1C reduction ≥2%: 100% (n=9)
 Improvement in adherence to ADA recommendations of 
screenings for:
• Retinopathy
• Neuropathy 
• Microalbuminuria
Conley MP, et. al. Curr Diab Rep. 2014;14:470-477. 45
Patient Case
 Patient went to her follow-up visit one week 
after being discharged and was able to get 
her inhaler
 She stated she had been able to reduce the 
number of cigarettes she smokes to ½ pack 
per day, but needs more than nicotine 
patches to help her entirely quit 
 Her PCP referred her to a 
pharmacist-led smoking 
cessation clinic
46
47
Financial Support
Cost-avoidance
 Reimbursement 
 MTM
 TOC*
 Chronic Disease Management* 
 Incidence to (hospital-based clinic)
*Requires a collaborative agreement with a physician
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Provider Status
 Will allow pharmacist to bill for their 
services independently 
 Will improve patient access to pharmacist 
provided services 
 Will help overcome barriers in 
incorporating pharmacists as integral 
members of interdisciplinary teams in the 
ambulatory setting
https://www.pharmacist.com/provider-status-what-pharmacists-need-know-now
49
Closing Thoughts
Pharmacist engagement in transitions of care progress…
…BUT there is more to do!
Pedersen CA, et al. AM J Health-Syst Pharm. 2017;74(17):1336-52. 50
Closing Thoughts
 Elements for effective transitions of care:
 Multidisciplinary support and collaboration
 Effective integration of the pharmacy team
 Data available to justify resources 
 Electronic patient information and data 
transfer 
 Strong partnership network
51
Self-assessment
True or False
1. Pharmacists’ role in TOC is limited to the 
inpatient setting. 
2. Harm from prescribed or omitted medications is 
higher after patients have been discharged from 
the hospital, mainly as a result of lack of 
communication between providers.
3. Implementation of TOC is well established in the 
inpatient setting. However, there is room for 
improvement in the TOC process once patients 
move to the outpatient setting.
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Thank You!
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